This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Informa
Menu
Book
DAY THREE WATCH LIVE (EST); 21/10/20keyboard_arrow_right

DAY THREE WATCH LIVE (EST); 21/10/20

keyboard_arrow_leftSearch & Filter
search

DAY THREE WATCH LIVE (EST); 21/10/20

search
This agenda is just the start. Wherever you are in the world, the Cell Therapy Bioprocessing & Commercialization and Cell Therapy Manufacturing & Gene Therapy Congresses are coming to you. The talks listed here are just the tip of the iceberg. Please also make sure to browse all of our 'on-demand' sessions which available to watch at your convenience.
7:30am - 7:50am20 mins
Cell Therapy
Analytical Method Development and Validation – Building the Characterization Testing Foundation & Toolkit
  • Lara Ionescu Silverman - Senior Director, Research and Development, DiscGenics
7:30am - 7:50am20 mins
Gene Edited Ex Vivo Cell Therapy
Analytical Method Development and Validation – Building the Characterization Testing Foundation & Toolkit
  • Lara Ionescu Silverman - Senior Director, Research and Development, DiscGenics
7:30am - 7:50am20 mins
In Vivo Gene Therapy
The Case for rAAV Titration by HPLC
  • Franz Schnetzinger - Director Analytical Development, Gyroscope Therapeutics
7:30am - 7:50am20 mins
Advanced Tools for Cell and Tissue Manufacturing: 20/20 View
Developing Your Manufacturing Process from A->Z
  • Priya Baraniak - Vice President, Corporate Development, OrganaBio
7:50am - 8:15am25 mins
Cell Therapy
Speaker Q&A - Cell Therapy Analytics – Testing, Characterization & Validation Strategies
  • Steve Oh - Director Stem Cell Bioprocessing & Institute Professor,, Bioprocessing Technology Institute
  • Lara Ionescu Silverman - Senior Director, Research and Development, DiscGenics
  • Barrett J. Nehila - Associate Director, Analytical Development, Torque Therapeutics
7:50am - 8:15am25 mins
Gene Edited Ex Vivo Cell Therapy
Speaker Q&A - Cell Therapy Analytics – Testing, Characterization & Validation Strategies
  • Steve Oh - Director Stem Cell Bioprocessing & Institute Professor,, Bioprocessing Technology Institute
  • Lara Ionescu Silverman - Senior Director, Research and Development, DiscGenics
  • Barrett J. Nehila - Associate Director, Analytical Development, Torque Therapeutics
7:50am - 8:15am25 mins
In Vivo Gene Therapy
Break
    7:50am - 8:10am20 mins
    Advanced Tools for Cell and Tissue Manufacturing: 20/20 View
    Development of Modular Biofabrication Platforms for Diverse Tissue Engineering Applications
    • George Joseph Christ - Professor of Biomedical Engineering and Orthopaedic Surgery, University of Virginia
    8:10am - 9:15am65 mins
    Cell Therapy
    Coffee Break & Exhibition Viewing Time
      8:10am - 9:15am65 mins
      Gene Edited Ex Vivo Cell Therapy
      Coffee Break & Exhibition Viewing Time
        8:10am - 9:15am65 mins
        In Vivo Gene Therapy
        Coffee Break & Exhibition Viewing Time
          8:10am - 9:15am65 mins
          Advanced Tools for Cell and Tissue Manufacturing: 20/20 View
          Coffee Break & Exhibition Viewing Time
            9:15am - 9:25am10 mins
            Cell Therapy
            Chairperson’s Opening Remarks
            • Anthony Davies, Ph.D. - Founder & CEO, Dark Horse Consulting
            9:15am - 9:25am10 mins
            Gene Edited Ex Vivo Cell Therapy
            Chairperson’s Opening Remarks
            • Anthony Davies, Ph.D. - Founder & CEO, Dark Horse Consulting
            9:15am - 9:25am10 mins
            In Vivo Gene Therapy
            Chairperson’s Opening Remarks
            • Anthony Davies, Ph.D. - Founder & CEO, Dark Horse Consulting
            9:15am - 9:25am10 mins
            Advanced Tools for Cell and Tissue Manufacturing: 20/20 View
            Chairperson’s Opening Remarks
            • Anthony Davies, Ph.D. - Founder & CEO, Dark Horse Consulting
            9:25am - 10:05am40 mins
            Cell Therapy
            State of the Industry
            • Michael Lehmicke - Director, Science and Industry Affairs, Alliance for Regenerative Medicine
            9:25am - 10:05am40 mins
            Gene Edited Ex Vivo Cell Therapy
            State of the Industry
            • Michael Lehmicke - Director, Science and Industry Affairs, Alliance for Regenerative Medicine
            9:25am - 10:05am40 mins
            In Vivo Gene Therapy
            State of the Industry
            • Michael Lehmicke - Director, Science and Industry Affairs, Alliance for Regenerative Medicine
            9:25am - 10:05am40 mins
            Advanced Tools for Cell and Tissue Manufacturing: 20/20 View
            State of the Industry
            • Michael Lehmicke - Director, Science and Industry Affairs, Alliance for Regenerative Medicine
            10:05am - 10:55am50 mins
            Cell Therapy
            PANEL: Reimbursement Models for Novel Therapies
            • Kevin W. Mayo - Managing Partner, Venture Genome LLC
            • Lisa Deschamps - SVP, Chief Business Officer, Novartis Gene Therapies
            • Phillip D. Carter - Head of U.S. Market Access, Orchard Therapeutics
            10:05am - 10:55am50 mins
            Gene Edited Ex Vivo Cell Therapy
            PANEL: Reimbursement Models for Novel Therapies
            • Kevin W. Mayo - Managing Partner, Venture Genome LLC
            • Lisa Deschamps - SVP, Chief Business Officer, Novartis Gene Therapies
            • Phillip D. Carter - Head of U.S. Market Access, Orchard Therapeutics
            10:05am - 10:55am50 mins
            In Vivo Gene Therapy
            PANEL: Reimbursement Models for Novel Therapies
            • Kevin W. Mayo - Managing Partner, Venture Genome LLC
            • Lisa Deschamps - SVP, Chief Business Officer, Novartis Gene Therapies
            • Phillip D. Carter - Head of U.S. Market Access, Orchard Therapeutics
            10:05am - 10:55am50 mins
            Advanced Tools for Cell and Tissue Manufacturing: 20/20 View
            PANEL: Reimbursement Models for Novel Therapies
            • Kevin W. Mayo - Managing Partner, Venture Genome LLC
            • Lisa Deschamps - SVP, Chief Business Officer, Novartis Gene Therapies
            • Phillip D. Carter - Head of U.S. Market Access, Orchard Therapeutics
            10:55am - 11:05am10 mins
            Cell Therapy
            Could we go paperless for cell therapy manufacturing? Vanderbilt adopts Chronicle software
            • Scott Sobecki - Director, Research Informatics, Vanderbilt University Medical Center, USA
            10:55am - 11:05am10 mins
            Gene Edited Ex Vivo Cell Therapy
            Could we go paperless for cell therapy manufacturing? Vanderbilt adopts Chronicle software
            • Scott Sobecki - Director, Research Informatics, Vanderbilt University Medical Center, USA
            10:55am - 11:05am10 mins
            In Vivo Gene Therapy
            Could we go paperless for cell therapy manufacturing? Vanderbilt adopts Chronicle software
            • Scott Sobecki - Director, Research Informatics, Vanderbilt University Medical Center, USA
            10:55am - 11:05am10 mins
            Advanced Tools for Cell and Tissue Manufacturing: 20/20 View
            Could we go paperless for cell therapy manufacturing? Vanderbilt adopts Chronicle software
            • Scott Sobecki - Director, Research Informatics, Vanderbilt University Medical Center, USA
            11:05am - 11:15am10 mins
            Cell Therapy
            Chronicle Roundtable Discussion
            • Per Hammer - Senior Product Manager, Cell & Gene Therapy Automation and Digital solutions, Cytiva, USA
            • Scott Sobecki - Director, Research Informatics, Vanderbilt University Medical Center, USA
            11:05am - 11:15am10 mins
            Gene Edited Ex Vivo Cell Therapy
            Chronicle Roundtable Discussion
            • Per Hammer - Senior Product Manager, Cell & Gene Therapy Automation and Digital solutions, Cytiva, USA
            • Scott Sobecki - Director, Research Informatics, Vanderbilt University Medical Center, USA
            11:05am - 11:15am10 mins
            In Vivo Gene Therapy
            Chronicle Roundtable Discussion
            • Per Hammer - Senior Product Manager, Cell & Gene Therapy Automation and Digital solutions, Cytiva, USA
            • Scott Sobecki - Director, Research Informatics, Vanderbilt University Medical Center, USA
            11:05am - 11:15am10 mins
            Advanced Tools for Cell and Tissue Manufacturing: 20/20 View
            Chronicle Roundtable Discussion
            • Per Hammer - Senior Product Manager, Cell & Gene Therapy Automation and Digital solutions, Cytiva, USA
            • Scott Sobecki - Director, Research Informatics, Vanderbilt University Medical Center, USA
            11:15am - 11:25am10 mins
            Cell Therapy
            Q&A
              11:15am - 11:25am10 mins
              Gene Edited Ex Vivo Cell Therapy
              Q&A
                11:15am - 11:25am10 mins
                In Vivo Gene Therapy
                Q&A
                  11:15am - 11:25am10 mins
                  Advanced Tools for Cell and Tissue Manufacturing: 20/20 View
                  Q&A
                    11:25am - 11:50am25 mins
                    Advanced Tools for Cell and Tissue Manufacturing: 20/20 View
                    Novel Bioreactor System for Fabrication of Musculoskeletal Tissues
                    • Lisa Larkin - Professor, Molecular & Integrative Physiology Professor, Biomedical Engineering, University of Michigan, USA
                    11:30am - 11:50am20 mins
                    Cell Therapy
                    Augmenting Automated Analytics for Cell & Gene Therapy Manufacture
                    • Veeren Chauhan - Nottingham Research Fellow in Bio-inspired Therapeutics in the Advanced Materials & Healthcare Technologies, University of Nottingham
                    11:30am - 11:50am20 mins
                    Gene Edited Ex Vivo Cell Therapy
                    Product Dependent Cryopreservation Protocols
                    • David McKenna - Professor and American Red Cross Chair in Transfusion Medicine, Department of Laboratory Medicine and Pathology, University of Minnesota
                    11:30am - 11:50am20 mins
                    In Vivo Gene Therapy
                    Emerging upstream bioprocessing and analytical tools for vector manufacture
                    • Michael J. DiBiasio-White, Sr. - Sr. Scientist: BioProcess Development/Protein Sciences, Ring Therapeutics
                    11:50am - 12:15pm25 mins
                    Cell Therapy
                    Speaker Q&A - Cell Therapy Analytics – Testing, Characterization & Validation Strategies
                    • Michael Roberts - Chief Technology Officer (Europe), Asklepios BioPharmaceutical, Inc.
                    • Qin Zou, Ph.D. - Senior Principal Scientist, Pfizer
                    • Jennifer L. Dashnau - Head of Analytical Development and Quality Control, Century Therapeutics, USA
                    11:50am - 12:15pm25 mins
                    Gene Edited Ex Vivo Cell Therapy
                    Speaker Q&A - Cryopreservation & Vein-to-vein Considerations
                    • Donald Singer - Consultant, formerly, GSK Senior Fellow, Microbiology, Biopharmaceutical GMP Operations, USA
                    • Jason Acker - Professor, Laboratory Medicine and Pathology, University of Alberta, Canada
                    • David McKenna - Professor and American Red Cross Chair in Transfusion Medicine, Department of Laboratory Medicine and Pathology, University of Minnesota
                    11:50am - 12:15pm25 mins
                    In Vivo Gene Therapy
                    Speaker Q&A - Gene Therapy Analytics
                    • Franz Schnetzinger - Director Analytical Development, Gyroscope Therapeutics
                    • David Dobnik - Scientific Associate, National Institute of Biology, Slovenia
                    • Michael J. DiBiasio-White, Sr. - Sr. Scientist: BioProcess Development/Protein Sciences, Ring Therapeutics
                    11:50am - 12:10pm20 mins
                    Advanced Tools for Cell and Tissue Manufacturing: 20/20 View
                    Microscale Sensors and Systems for Tissue Engineering and Organs on a Chip Applications
                    • Mehmet Dokmeci - Adjunct Professors, University of California (UCLA)
                    12:10pm - 12:55pm45 mins
                    Cell Therapy
                    Exhibition Viewing Time & Live Labs
                      12:10pm - 12:55pm45 mins
                      Gene Edited Ex Vivo Cell Therapy
                      Exhibition Viewing Time & Live Labs
                        12:10pm - 12:55pm45 mins
                        In Vivo Gene Therapy
                        Exhibition Viewing Time & Live Labs
                          12:10pm - 12:55pm45 mins
                          Advanced Tools for Cell and Tissue Manufacturing: 20/20 View
                          Exhibition Viewing Time & Live Labs
                            DAY TWO WATCH LIVE (EST); 20/10/20
                            NextDAY FOUR WATCH LIVE (EST); 22/10/20

                            Get the latest news.
                            As it happens

                            Sign up to get the latest on the agenda and speakers.
                            Filter
                            Streams
                            Choose Day